{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:24:22Z","timestamp":1741152262131,"version":"3.38.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"DOI":"10.7759\/cureus.80004","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T07:11:50Z","timestamp":1741072310000},"source":"Crossref","is-referenced-by-count":0,"title":["Racing to Normal: A Case Report of Rapid and Notable Cholesterol Reduction With Statin and Ezetimibe Combined Therapy"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Apar\u00edcio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Guideline for the pharmacological treatment of hypertension in adults. summary. (2022). Accessed: 24\/02\/2025: https:\/\/iris.who.int\/bitstream\/handle\/10665\/356108\/9789240050969-eng.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen C","year":"2023","unstructured":"Magnussen C, Ojeda FM, Leong DP, et al.. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 2023, 389:1273-85. 10.1056\/NEJMoa2206916","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.039","article-title":"Correction","volume":"77","year":"2021","unstructured":"Correction. J Am Coll Cardiol. 2021, 77.1958-9. 10.1016\/j.jacc.2021.02.039","journal-title":"J Am Coll Cardiol"},{"key":"ref4","article-title":"Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization","year":"2021","unstructured":"Guideline for the Pharmacological Treatment of Hypertension in Adults. World Health Organization, Geneva; 2021. https.\/\/www.ncbi.nlm.nih.gov\/books\/NBK573631\/."},{"key":"ref5","unstructured":"Preval\u00eancia de fatores de risco cardiovascular na popula\u00e7\u00e3o portuguesa. (2019). Accessed. 24\/02\/2025: https:\/\/www.insa.min-saude.pt\/wp-content\/uploads\/2020\/02\/e_COR_relatorio.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae199","article-title":"Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study","volume":"31","author":"Ray KK","year":"2024","unstructured":"Ray KK, Aguiar C, Arca M, et al.. Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study. Eur J Prev Cardiol. 2024, 31:1792-803. 10.1093\/eurjpc\/zwae199","journal-title":"Eur J Prev Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren FL","year":"2021","unstructured":"Visseren FL, Mach F, Smulders YM, et al.. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021, 42:3227-337. 10.1093\/eurheartj\/ehab484","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0195-668x(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp RH","year":"2003","unstructured":"Knopp RH, Gitter H, Truitt T, et al.. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003, 24:729-41. 10.1016\/s0195-668x(02)00807-2","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration","year":"2021","unstructured":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021, 42:2439-54. 10.1093\/eurheartj\/ehab309","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347726-racing-to-normal-a-case-report-of-rapid-and-notable-cholesterol-reduction-with-statin-and-ezetimibe-combined-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T07:11:52Z","timestamp":1741072312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347726-racing-to-normal-a-case-report-of-rapid-and-notable-cholesterol-reduction-with-statin-and-ezetimibe-combined-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.80004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}